MicroRNA‐155 is a predictive marker for survival in patients with clear cell renal cell carcinoma
Authors:
Open Access
- 10 October 2012
- journal article
- research article
- Published by Wiley in International Journal of Urology
- Vol. 20 (5) , 468-477
Abstract
Objectives: To investigate the clinical significance of micro‐ribonucleic acid‐155 in clear cell renal cell carcinoma, in particular focusing on the association of expression levels of micro‐ribonucleic acid‐155 with clinicopathological factors, cancer‐specific survival and therapeutic outcomes in clear cell renal cell carcinoma patients.Methods: Quantitative reverse transcription polymerase chain reaction of micro‐ribonucleic acid‐155 was carried out on 137 clear cell renal cell carcinoma cases, containing 77 matched pairs of clear cell renal cell carcinoma and normal adjacent kidney tissues from the same patients.Results: Significant overexpression of micro‐ribonucleic acid‐155 was found in clear cell renal cell carcinoma compared with normal kidney tissue. Expression of micro‐ribonucleic acid‐155 was not associated with prognosis in all stage groups. However, in 43 patients with stage III and IV clear cell renal cell carcinoma, low expression levels of micro‐ribonucleic acid‐155 correlated with a poor prognosis. Regarding cancer‐free survival of 26 patients with stage III and IV clear cell renal cell carcinoma who received curative resection and cancer‐specific survival of 31 patients who received postoperative therapy with interferon‐α after radical nephrectomy, low expression levels of micro‐ribonucleic acid‐155 correlated with poor clinical outcomes in these two groups.Conclusions: Low expression of micro‐ribonucleic acid‐155 represents a valuable marker of poor clinical outcomes in patients with stage III and IV clear cell renal cell carcinoma.Keywords
This publication has 30 references indexed in Scilit:
- MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1α Activity during Prolonged HypoxiaMolecular and Cellular Biology, 2011
- Immunoexpression Status and Prognostic Value of mTOR and Hypoxia-Induced Pathway Members in Primary and Metastatic Clear Cell Renal Cell CarcinomasAmerican Journal of Surgical Pathology, 2011
- miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA DysregulationJournal of Urology, 2011
- The VHL-dependent regulation of microRNAs in renal cancerBMC Medicine, 2010
- Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomyJournal of Experimental & Clinical Cancer Research, 2010
- Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAsBiological Chemistry, 2010
- Inositol phosphatase SHIP1 is a primary target of miR-155Proceedings of the National Academy of Sciences, 2009
- Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentProceedings of the National Academy of Sciences, 2007
- MicroRNA expression profiles classify human cancersNature, 2005
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002